Here are four observations:
1. The award recognizes companies for achievements and superior performance in technological innovation and strategic product development in the orthopedic biomaterial market.
2. BONESUPPORT’s proprietary biomaterial product, CERAMENT, is a platform technology currently available under four product lines — CERAMENT|G, CERAMENT|V, CERAMENT|BONE VOID FILLER and CERAMENT| SPINE SUPPORT.
3. CERAMENT|G and CERAMENT|V are the first CE-marked injectable bone substitutes with antibiotics indicated to promote bone healing.
4. More than 45 pre-clinical, clinical and animal studies have been conducted and more than 10,000 patients have been treated with CERAMENT, which is available in the United States, Europe, Southeast Asia and the Middle East.
More articles on devices:
Wall Street analysts’ mean target price for NuVasive stock is $54.9 — 4 observations
Allegheny Health Network incorporates MAKOplasty — 4 quick facts
Ellipse Technologies’ new external remote controller for MAGEC system receives FDA clearance: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
